Re: Validation of an RNA Cell Cycle Progression Score for Predicting Death from Prostate Cancer in a Conservatively Managed Needle Biopsy Cohort Editorial Comment

被引：0

作者：

Cuzick, J. ^{[1
]}

Stone, S.

Fisher, G.

Yang, Z. H.

North, B. V.

Berney, D. M.

Beltran, L.

Greenberg, D.

Moller, H.

Reid, J. E.

Gutin, A.

Lanchbury, J. S.

Brawer, M.

Scardino, P.

机构：

[1] Queen Mary Univ, Wolfson Inst Prevent Med, Ctr Canc Prevent, London, England

来源：

JOURNAL OF UROLOGY | 2016年 / 195卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1779 / 1780

页数：2

共 50 条

[31] Re: Baseline Prostate Inflammation is Associated with a Reduced Risk of Prostate Cancer in Men Undergoing Repeat Prostate Biopsy: Results from the REDUCE Study Editorial Comment
Taneja, Samir S.
JOURNAL OF UROLOGY, 2014, 192 (01): : 128 - 128
[32] Cell cycle progression score differentiates indolent from aggressive prostate cancer in men diagnosed by TURP.
Cuzick, Jack M.
Stone, Steven
Rajamani, Saradha
Moller, Henrik
Berney, Daniel M.
Cohen, Todd
Scardino, Peter T.
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[33] Reply to Editorial Comment on "PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort"
Checcucci, Enrico
Bauckneht, Matteo
Gandaglia, Giorgio
Porpiglia, Francesco
UROLOGY, 2025, 196 : 187 - 188
[34] Re: Role of Surveillance Biopsy with no Cancer as a Prognostic Marker for Reclassification: Results from the Canary Prostate Active Surveillance Study Editorial Comment
Taneja, Samir S.
JOURNAL OF UROLOGY, 2018, 200 (01): : 30 - 30
[35] Validation of the Decipher prostate cancer classifier for predicting 10-year postoperative metastasis from analysis of diagnostic needle biopsy specimens.
Magi-Galluzzi, Cristina
Yousefi, Kasra
Haddad, Zaid
Palmer-Aronsten, Beatrix
Lam, Lucia L. C.
Buerki, Christine
Li, Jianbo
Kattan, Michael W.
Stephenson, Andrew J.
Davicioni, Elai
Klein, Eric A.
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
[36] Re: Prognostic Utility of Biopsy-Derived Cell Cycle Progression Score in Patients with National Comprehensive Cancer Network Low-Risk Prostate Cancer Undergoing Radical Prostatectomy: Implications for Treatment Guidance
Taneja, Samir S.
JOURNAL OF UROLOGY, 2017, 198 (05): : 981 - 981
[37] Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy EDITORIAL COMMENT
Glaser, Zachary A.
Rais-Bahrami, Soroush
JOURNAL OF UROLOGY, 2019, 201 (01): : 90 - 90
[38] Re: Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study Editorial Comment
Taneja, Samir S.
JOURNAL OF UROLOGY, 2015, 194 (06): : 1632 - 1632
[39] Comparison of cell cycle progression score with two immunohistochemical markers (PTEN and Ki-67) for predicting outcome in prostate cancer after radical prostatectomy
Priscilla Léon
Geraldine Cancel-Tassin
Sara Drouin
Marie Audouin
Justine Varinot
Eva Comperat
Xavier Cathelineau
François Rozet
Christophe Vaessens
Steven Stone
Julia Reid
Zaina Sangale
Patrick Korman
Morgan Rouprêt
Gaelle Fromond-Hankard
Olivier Cussenot
World Journal of Urology, 2018, 36 : 1495 - 1500
[40] Validation of the Combined Clinical Cell-Cycle Risk Score to Prognosticate Early Prostate Cancer Metastasis From Biopsy Specimens and Comparison With Other Routinely Used Risk Classifiers
Hutten, Ryan J.
Odei, Bismarck
Johnson, Skyler B.
Tward, Jonathan D.
JCO PRECISION ONCOLOGY, 2024, 8

← 1 2 3 4 5 →